Table 1. Clinicopathological characteristics of 16 PDAC patients with and without HAMP+.
| Variable | HAMP+ (n = 4) | HAMP− (n = 12) | Total (n = 16) | P | |
|---|---|---|---|---|---|
| Age (years) | 58.3 (46–70) | 69.5 (33–81) | 66.7 (33–81) | 0.674 | |
| Gender | M | 3 | 4 | 7 | 0.146 |
| F | 1 | 8 | 9 | ||
| serum CEA (ng/mL) | 5.75 (2.8–8.4) | 5.79 (1–13.6) | 5.78 (1–13.6) | 0.983 | |
| serum CA19.9 (U/mL) | 115.8 (15.4–328.3) | 156.5 (0.8–989.4) | 146.3 (0.8–989.4) | 0.712 | |
| UICC-T | 0.485 | ||||
| pT1 | 0 | 2 | 2 | ||
| pT2 | 1 | 2 | 3 | ||
| pT3 | 3 | 5 | 8 | ||
| pT4 | 0 | 3 | 3 | ||
| UICC-N | 0.728 | ||||
| pN0 | 1 | 3 | 4 | ||
| pN1 | 3 | 9 | 12 | ||
| UICC-M | NA | ||||
| pM0 | 4 | 12 | 16 | ||
| pM1 | 0 | 0 | 0 | ||
| UICC-Stage | 0.545 | ||||
| IA | 0 | 1 | 1 | ||
| IB | 1 | 1 | 2 | ||
| IIA | 0 | 0 | 0 | ||
| IIB | 3 | 7 | 10 | ||
| III | 0 | 3 | 3 | ||
| IV | 0 | 0 | 0 | ||
| Histological grade | 0.62 | ||||
| Well | 4 | 8 | 12 | ||
| Mod | 0 | 1 | 1 | ||
| Poor | 0 | 2 | 2 | ||
| Mucinous | 0 | 1 | 1 | ||
| Lymphatic invasion | 0.62 | ||||
| + | 0 | 2 | 2 | ||
| − | 4 | 10 | 14 | ||
| Vessel invasion | 0.182 | ||||
| + | 0 | 4 | 4 | ||
| − | 4 | 8 | 12 | ||
| Neural invasion | 0.712 | ||||
| + | 1 | 2 | 3 | ||
| − | 3 | 10 | 13 | ||
| Residual tumor | 0.18 | ||||
| R0 | 3 | 11 | 14 | ||
| R1 | 1 | 0 | 1 | ||
| R2 | 0 | 1 | 1 | ||
| Adjuvant chemotherapy | 0.712 | ||||
| + | 1 | 2 | 3 | ||
| − | 3 | 10 | 13 |